EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 72 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 72 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 72 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 72 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | – | 72 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 72 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | – | 72 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 72 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 72 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 72 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 72 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 72 | -42.4% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 125 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 125 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 125 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | +100.0% | 125 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 125 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | -50.0% | 125 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | – | 125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Simplify Asset Management Inc. | 2,700,000 | $823,500 | 0.09% |
| 683 Capital Management, LLC | 2,650,000 | $808,250 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 355,867 | $109 | 0.01% |
| RBF Capital, LLC | 391,265 | $119,336 | 0.01% |
| UBS OCONNOR LLC | 393,975 | $120,162 | 0.00% |
| XTX Topco Ltd | 15,597 | $4,757 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $32,544 | 0.00% |
| AMERIPRISE FINANCIAL INC | 8,592,471 | $2,620,704 | 0.00% |
| DRW Securities, LLC | 120,365 | $37 | 0.00% |
| DFPG INVESTMENTS, LLC | 32,430 | $10,896 | 0.00% |